Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled study of SPM962 in early Parkinson's disease
jRCT2080220443Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2007
- Countries
- 1
01
Overview
Phase 3, randomised trial in Parkinson's disease (PD) (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080220443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220443.